Literature DB >> 20356821

FGFR3 down-regulates PTH/PTHrP receptor gene expression by mediating JAK/STAT signaling in chondrocytic cell line.

Minqi Li1, Yukie Seki, Paulo H L Freitas, Masaki Nagata, Taku Kojima, Sara Sultana, Sobhan Ubaidus, Takeyasu Maeda, Junko Shimomura, Janet E Henderson, Masato Tamura, Kimimitsu Oda, Zhusheng Liu, Ying Guo, Reiko Suzuki, Tsuneyuki Yamamoto, Ritsuo Takagi, Norio Amizuka.   

Abstract

The signaling axis comprising the parathyroid hormone (PTH)-related peptide (PTHrP), the PTH/PTHrP receptor and the fibroblast growth factor receptor 3 (FGFR3) plays a central role in chondrocyte proliferation. The Indian hedgehog (IHH) gene is normally expressed in early hypertrophic chondrocytes, and its negative feedback loop was shown to regulate PTH/PTHrP receptor signaling. In this study, we examined the regulation of PTH/PTHrP receptor gene expression in a FGFR3-transfected chondrocytic cell line, CFK2. Expression of IHH could not be verified on these cells, with consequent absence of hypertrophic differentiation. Also, expression of the PTH/PTHrP receptor (75% reduction of total mRNA) and the PTHrP (50% reduction) genes was reduced in CFK2 cells transfected with FGFR3 cDNA. Interestingly, we verified significant reduction in cell growth and increased apoptosis in the transfected cells. STAT1 was detected in the nuclei of the CFK2 cells transfected with FGFR3 cDNA, indicating predominance of the JAK/STAT signaling pathway. The reduction in PTH/PTHrP receptor gene in CFK2 cells overexpressing FGFR3 was partially blocked by treatment with an inhibitor of JAK3 (WHI-P131), but not with an inhibitor of MAPK (SB203580) or JAK2 (AG490). Altogether, these findings suggest that FGFR3 down-regulates PTH/PTHrP receptor gene expression via the JAK/STAT signaling in chondrocytic cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20356821     DOI: 10.1093/jmicro/dfq002

Source DB:  PubMed          Journal:  J Electron Microsc (Tokyo)        ISSN: 0022-0744


  6 in total

1.  FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth.

Authors:  Kannan Karuppaiah; Kai Yu; Joohyun Lim; Jianquan Chen; Craig Smith; Fanxin Long; David M Ornitz
Journal:  Development       Date:  2016-04-06       Impact factor: 6.868

Review 2.  Genetics of Short Stature.

Authors:  Youn Hee Jee; Anenisia C Andrade; Jeffrey Baron; Ola Nilsson
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-23       Impact factor: 4.741

Review 3.  Mechanisms of synovial joint and articular cartilage development.

Authors:  Ryota Chijimatsu; Taku Saito
Journal:  Cell Mol Life Sci       Date:  2019-06-14       Impact factor: 9.261

Review 4.  Molecular therapeutic strategies for FGFR3 gene-related skeletal dysplasia.

Authors:  Jia Chen; Jiaqi Liu; Yangzhong Zhou; Sen Liu; Gang Liu; Yuzhi Zuo; Zhihong Wu; Nan Wu; Guixing Qiu
Journal:  J Mol Med (Berl)       Date:  2017-10-23       Impact factor: 4.599

Review 5.  Fibroblast growth factor signaling in skeletal development and disease.

Authors:  David M Ornitz; Pierre J Marie
Journal:  Genes Dev       Date:  2015-07-15       Impact factor: 11.361

6.  Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice.

Authors:  Yangli Xie; Lingxian Yi; Tujun Weng; Junlan Huang; Fengtao Luo; Wanling Jiang; Cory J Xian; Xiaolan Du; Lin Chen
Journal:  Int J Biol Sci       Date:  2016-07-17       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.